Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers

Pediatric Infectious Disease Journal

Volumn 30, Issue 4, 2011, Pages 325-330

  Kolte, Lilian ^a   Rosenfeldt, Vibeke ^a   Vang, Lena ^a   Jeppesen, Dorthe ^a   Karlsson, Ingrid ^b   Ryder, Lars Peter ^c   Skogstrand, Kristin ^b   Nielsen, Susanne Dam ^c  

^a Mental Health Center Glostrup   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

HIV exposed uninfected children; Regulatory T cells; Thymic output; Vaccination response

Indexed keywords

CYTOKINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; T LYMPHOCYTE RECEPTOR;

ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; PHENOTYPE; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYMUS ATROPHY; THYMUS FUNCTION; VACCINATION;

EID: 79954708065     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182019bc3     Document Type: Article

References (44)

1. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308:1582-1583. (Pubitemid 40807496)
2. Burns DN, Mofenson LM. Paediatric HIV-1 infection. Lancet. 1999; 354(suppl 2):SII1-SII6.
3. Kind C, Rudin C, Siegrist CA, et al. Swiss Neonatal HIV Study Group. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS. 1998;12:205-210. (Pubitemid 28035162)
4. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
5. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudinezidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285:2083-2093. (Pubitemid 32367825)
6. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14:276-287.
7. Clerici M, Saresella M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000;96:3866-3871.
8. Nielsen SD, Jeppesen DL, Kolte L, et al. Impaired progenitor cell function in HIV-negative infants of HIV- positive mothers results in decreased thymic output and low CD4 counts. Blood. 2001;98:398-404.
9. Ono E, Nunes dos Santos AM, de Menezes Succi RC, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res. 2008;41:700-708.
10. Rich KC, Siegel JN, Jennings C, et al. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997;4:358-361. (Pubitemid 27239698)
11. Bunders MJ, Bekker V, Scherpbier HJ, et al. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr. 2005;94:1571-1577. (Pubitemid 41754310)
12. Feiterna-Sperling C, Weizsaecker K, Buhrer C, et al. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr. 2007; 45:43-51. (Pubitemid 46684442)
13. Legrand FA, Nixon DF, Loo CP, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE. 2006;1:e102.
14. Levy JA, Hsueh F, Blackbourn DJ, et al. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. J Infect Dis. 1998;177:470-472. (Pubitemid 28063778)
15. Rowland-Jones SL, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 1993;341: 860-861. (Pubitemid 23094512)
16. European Collaborative Study Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS. 2004;18:2009 -2017.
17. Le CJ, Mayaux MJ, Guihenneuc-Jouyaux C, et al. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS. 2003;17: 2053-2061. (Pubitemid 37297153)
18. Pacheco SE, McIntosh K, Lu M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infect Dis. 2006;194:1089-1097. (Pubitemid 44547648)
19. Clark DR, Repping S, Pakker NG, et al. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. Blood. 2000;96:242-249. (Pubitemid 30456477)
20. Dam NS, Kjaer EA, Mathiesen L, et al. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis. 1998;178:1299-1305. (Pubitemid 28523266)
21. Jeppesen D, Hasselbalch H, Ersboll AK, et al. Thymic size in uninfected infants born to HIV-positive mothers and fed with pasteurized human milk. Acta Paediatr. 2003;92:679-683. (Pubitemid 37088675)
22. Kolte L, Dreves AM, Ersboll AK, et al. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis. 2002;185:1578-1585. (Pubitemid 34587519)
23. Kolte L, Gaardbo JC, Skogstrand K, et al. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol. 2009;155:44-52.
24. de St Groth BF, Landay AL. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS. 2008;22: 671-683. (Pubitemid 351450635)
25. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS. 2005;19:1071-1079. (Pubitemid 40961148)
26. Helfand RF, Witte D, Fowlkes A, et al. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis. 2008;198:1457-1465.
27. Mansoor N, Scriba TJ, de Koch M, et al. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine. J Infect Dis. 2009;199:982-990.
28. Lima M, de Menezes Succi RC, Nunes dos Santos AM, et al. Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies. Pediatr Infect Dis J. 2004;23: 604-607. (Pubitemid 38924882)
29. Bunders M, Lugada E, Mermin J, et al. Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda. Ann Trop Paediatr. 2006;26:169-179. (Pubitemid 47054027)
30. Gaulton GN, Scobie JV, Rosenzweig M. HIV-1 and the thymus. AIDS. 1997;11:403-414. (Pubitemid 27113000)
31. Papiernik M, Brossard Y, Mulliez N, et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics. 1992;89:297-301.
32. Mansoor N, Abel B, Scriba TJ, et al. Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol. 2009;130:280-289.
33. Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609-4616. (Pubitemid 26174440)
34. Hasselbalch H, Ersboll AK, Jeppesen DL, et al. Thymus size in infants from birth until 24 months of age evaluated by ultrasound. A longitudinal prediction model for the thymic index. Acta Radiol. 1999;40:41-44. (Pubitemid 129551567)
35. Aaby P, Marx C, Trautner S, et al. Thymus size at birth is associated with infant mortality: a community study from Guinea-Bissau. Acta Paediatr. 2002;91:698-703. (Pubitemid 34779334)
36. Garly ML, Trautner SL, Marx C, et al. Thymus size at 6 months of age and subsequent child mortality. J Pediatr. 2008;153:683-688, 688.e1-688.e3.
37. Hasselbalch H, Jeppesen DL, Ersboll AK, et al. Sonographic measurement of thymic size in healthy neonates. Relation to clinical variables. Acta Radiol. 1997;38:95-98. (Pubitemid 127459524)
38. Jeppesen DL, Hasselbalch H, Lisse IM, et al. T-lymphocyte subsets, thymic size and breastfeeding in infancy. Pediatr Allergy Immunol. 2004;15:127-132. (Pubitemid 38480780)
39. Kohler S, Thiel A. Life after the thymus: CD31+ and. Blood. 2009;113: 769-774.
40. Hazenberg MD, Otto SA, Cohen Stuart JW, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042.
41. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881-1888. (Pubitemid 37070273)
42. Kinter AL, Hennessey M, Bell A, et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med. 2004;200:331-343. (Pubitemid 39031252)
43. Fritzsching B, Oberle N, Pauly E, et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood. 2006;108:3371-3378.
44. Haas J, Fritzsching B, Trubswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol. 2007;179: 1322-1330.